Cargando…
Targeting the mTOR Pathway for the Prevention of ER-Negative Breast Cancer
Prevention of estrogen receptor (ER)-positive breast cancer is now possible using anti-estrogen drugs; however, this treatment is ineffective against ER-negative breast cancers. In this study, we hypothesized that inhibition of mTOR will suppress the growth of ER-negative and triple-negative breast...
Autores principales: | Mazumdar, Abhijit, Tahaney, William M., Hill, Jamal L., Zhang, Yun, Ramachandran, Sumankalai, Kawedia, Jitesh, Qian, Jing, Contreras, Alejandro, Savage, Michelle I., Vornik, Lana A., Sei, Shizuko, Mohammed, Altaf, Brown, Powel H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for Cancer Research
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9762336/ https://www.ncbi.nlm.nih.gov/pubmed/35981902 http://dx.doi.org/10.1158/1940-6207.CAPR-22-0106 |
Ejemplares similares
-
380 The kinesin-like protein Kif11 is essential for the survival of TP53 mutant triple-negative breast cancer cells
por: Lanier, Amanda, et al.
Publicado: (2023) -
The phosphatase PPM1A inhibits triple negative breast cancer growth by blocking cell cycle progression
por: Mazumdar, Abhijit, et al.
Publicado: (2019) -
Mutant P53 induces MELK expression by release of wild-type P53-dependent suppression of FOXM1
por: Bollu, Lakshmi Reddy, et al.
Publicado: (2020) -
Analysis of phosphatases in ER-negative breast cancers identifies DUSP4 as a critical regulator of growth and invasion
por: Mazumdar, Abhijit, et al.
Publicado: (2016) -
Glucose Regulation of Load‐Induced mTOR Signaling and ER Stress in Mammalian Heart
por: Sen, Shiraj, et al.
Publicado: (2013)